DBL Potassium Dihydrogen Phosphate Contraindications

Phosphate administration is contraindicated in patients with severe renal function impairment (less than 30% normal) since there is an increased risk of hyperphosphataemia in these patients.
Phosphate administration is contraindicated in patients with hyperphosphataemia, since phosphate therapy will exacerbate the condition.
Phosphate administration is contraindicated in patients with hypocalcaemia due to the close relationship between hypocalcaemia and hyperphosphataemia.
DBL Potassium Dihydrogen Phosphate Concentrated Injection is contraindicated in patients with hyperkalaemia, since the potassium in the injection may exacerbate the condition.
DBL Potassium Dihydrogen Phosphate Concentrated Injection is contraindicated in Addison's disease since there is an increased risk of hyperkalaemia in these patients.
Phosphate administration is contraindicated in urolithiasis (magnesium ammonium phosphate type, infected) since it may exacerbate the condition.